February 5, 2004
By
Charles Choi
The Scientist Inc.
Greenpeace,
Indian groups challenge company's rights to strain known as Nap
Hal
Greenpeace is
challenging patent rights to a wheat strain granted
to Monsanto, the world's
largest genetically modified (GM) seed company, on grounds of
“biopiracy.” The dispute continues the environmental group's
demands against patenting of any plants, animals, humans, and
genes.
Greenpeace
says the patented variety of wheat possesses genetic
characteristics originally derived from a strain known as Nap
Hal used to make chapatis, the flat bread traditional to
northern India.
“Monsanto is
trying to get ownership of the specific genetic traits of Nap
Hal,” Greenpeace Genetic Engineering Campaigner Christoph Then
told The Scientist. “It's robbery of generations of
effort in cultivation of Indian farmers.”
The company
vigorously denied the allegations. “The people opposing the
patent allege there's nothing novel here. But it is indeed a
novel invention,” Monsanto Europe–Africa's Director of Public
Affairs Thomas McDermott said. “The patent has been granted, and
we will defend it.”
Nap Hal has
less gluten than other wheat varieties, which gives it lower
viscoelasticity, meaning it expands less during baking. This
makes it perfect for crisp breads such as chapatis.
Unilever
obtained Nap Hal seeds from public seed banks and bred a variety
dubbed Galatea from it. Monsanto acquired Galatea when it bought
Unilever in 1998. The European Patent Office granted
patent
number EP445929 for the strain last May. The Unite
States had issued Unilever patents regarding low-viscoelasticity
wheat strains in
1998
and
1999.
Greenpeace
filed legal opposition to the patent at the European Patent
Office on January 27, with the support of the India-based
Research
Foundation for Science, Technology and Ecology and
the Indian farmers' organization Bharat Krishak Samaj.
“The
technical features of the plants described in the patent are
typical of seed which is grown normally and not allowed to be
patented,” the opposition stated. “The patent owners have not
added anything new to what is state of the art; they have merely
described known features of wheat plants in such a way that they
are supposed to look as if they are new.”
The activists
added that “keeping the patent would mean illegal monopolization
of important genetic plant resources,” and could block
cultivation of all related varieties.
Monsanto
denied the patents would be used to block Indian farmers from
using their Nap Hal seed.
“Indian users
can use Nap Hal for chapatis or whatever else, now and just as
they've always been used to,” McDermott told The Scientist.
“The idea that Indian farmers would have to pay royalties to use
Nap Hal, that's just inflammatory and ridiculous.”
While the
patent applies in 13 European countries as well as Japan,
Australia, Canada and the United States, it was not granted in
India. This means Monsanto would not have control over their new
variety there, McDermott said. But the company has not
commercialized Galatea, and “Monsanto is planning to exit the
wheat business in Europe,” McDermott said. “There should be no
controversy at all.”
“Indian
farmers should worry about this,” Then said. “It's their effort
stolen from them. Indian farmers and politicians should at least
now be warier of the implications that could come up in
exclusivity of patents. It might prove relevant for all export
facilities of the wheat from India. In a larger context, this
controversy is relevant for all farmers.”
Then said he
felt confident Greenpeace will win “on the point that this
patent clearly covers plant varieties, which cannot be patented
in Europe.”
“There are
some funny things with how Europe runs patents. They allow
patents on plants but not on plant varieties,” said patent agent
Peter DiMauro of the National Center for Technology Assessment
in Washington, DC.
Then said the
European Patent Convention forbids patents on plant varieties,
but the European Directive from 1998 allows patents on plants
that are not a variety. “In fact, nobody can draw a clear line
between these two legal frameworks,” Then said.
“You can
claim something higher than the taxonomical status of a plant
variety, but can't claim anything limited to a plant variety,”
DiMauro told The Scientist. “It's logical insanity.”
Links for
this article
“Greenpeace and Indian farmers raise objection against patent on
Indian wheat,”
Greenpeace press release, January 27, 2004.
http://www.greenpeace.org/deutschland/?page=/deutschland/pe/gen
technik/27-01-04--einspruch-gegen-patent-auf-weizen
European Patent Number EP0445929, November 9, 1991
http://v3.espacenet.com/textdoc?DB=EPODOC&IDX=EP0445929
US Patent Number 5,763,741, June 9, 1998
http://patft.uspto.gov/
US Patent Number 5,859,315, January 12, 1999
http://patft.uspto.gov/
Research Foundation for Science, Technology and Ecology
http://www.vshiva.net/
©2004,
The Scientist Inc. in
association with BioMed
Central. |